Therefore, PDIA3 may become a new candidate marker for the diagnosis of renal cell carcinoma, which provides important significance for early clinical diagnosis of renal cell carcinoma. This evidence concerns the gene PDIA3 and hereditary clear cell renal cell carcinoma.